Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.

Song A, Andrews DW, Werner-Wasik M, Kim L, Glass J, Bar-Ad V, Evans JJ, Farrell CJ, Judy KD, Daskalakis C, Zhan T, Shi W.

Radiother Oncol. 2019 Mar;132:135-141. doi: 10.1016/j.radonc.2018.12.019. Epub 2019 Jan 4.

PMID:
30825962
2.

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.

Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):22-30. doi: 10.1016/j.ijrobp.2017.05.028. Epub 2017 May 26.

PMID:
28816150
3.

Cryptococcal ventriculoperitoneal shunt infection.

Viereck MJ, Chalouhi N, Krieger DI, Judy KD.

J Clin Neurosci. 2014 Nov;21(11):2020-1. doi: 10.1016/j.jocn.2014.08.001. Epub 2014 Sep 12.

PMID:
25220283
4.

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.

Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP.

J Neurooncol. 2014 Jun;118(2):313-319. doi: 10.1007/s11060-014-1433-2. Epub 2014 Apr 13.

PMID:
24728831
5.

Clinically silent somatotroph adenomas are common.

Wade AN, Baccon J, Grady MS, Judy KD, O'Rourke DM, Snyder PJ.

Eur J Endocrinol. 2011 Jul;165(1):39-44. doi: 10.1530/EJE-11-0216. Epub 2011 Apr 14.

6.

Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.

Wang S, Kim S, Chawla S, Wolf RL, Knipp DE, Vossough A, O'Rourke DM, Judy KD, Poptani H, Melhem ER.

AJNR Am J Neuroradiol. 2011 Mar;32(3):507-14. doi: 10.3174/ajnr.A2333. Epub 2011 Feb 17.

7.

Concurrent Cochlear Implantation with Resection of Skull Base Hemangiopericytoma following Sudden Deafness in an Only Hearing Ear.

Ransom ER, Judy KD, Bigelow DC.

Skull Base. 2010 Jul;20(4):279-84. doi: 10.1055/s-0030-1247633.

8.

Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.

Koch CJ, Scheuermann JS, Divgi C, Judy KD, Kachur AV, Freifelder R, Reddin JS, Karp J, Stubbs JB, Hahn SM, Driesbaugh J, Smith D, Prendergast S, Evans SM.

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2048-59. doi: 10.1007/s00259-010-1517-y. Epub 2010 Jun 29.

9.

The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.

Evans SM, Jenkins KW, Chen HI, Jenkins WT, Judy KD, Hwang WT, Lustig RA, Judkins AR, Grady MS, Hahn SM, Koch CJ.

Transl Oncol. 2010 Jun 1;3(3):160-9.

10.

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.

Kapoor GS, Gocke TA, Chawla S, Whitmore RG, Nabavizadeh A, Krejza J, Lopinto J, Plaum J, Maloney-Wilensky E, Poptani H, Melhem ER, Judy KD, O'Rourke DM.

J Neurooncol. 2009 May;92(3):373-86. doi: 10.1007/s11060-009-9880-x. Epub 2009 Apr 9.

PMID:
19357963
11.

Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.

Evans SM, Jenkins KW, Jenkins WT, Dilling T, Judy KD, Schrlau A, Judkins A, Hahn SM, Koch CJ.

Radiat Res. 2008 Dec;170(6):677-90. doi: 10.1667/RR1207.1.

12.

Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.

Chawla S, Oleaga L, Wang S, Krejza J, Wolf RL, Woo JH, O'Rourke DM, Judy KD, Grady MS, Melhem ER, Poptani H.

J Neuroimaging. 2010 Jan;20(1):3-8. doi: 10.1111/j.1552-6569.2008.00307.x.

PMID:
19021846
13.

Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.

Wang S, Kim S, Chawla S, Wolf RL, Zhang WG, O'Rourke DM, Judy KD, Melhem ER, Poptani H.

Neuroimage. 2009 Feb 1;44(3):653-60. doi: 10.1016/j.neuroimage.2008.09.027. Epub 2008 Oct 7.

14.

Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas.

Chawla S, Wang S, Wolf RL, Woo JH, Wang J, O'Rourke DM, Judy KD, Grady MS, Melhem ER, Poptani H.

AJNR Am J Neuroradiol. 2007 Oct;28(9):1683-9. Epub 2007 Sep 24.

15.

Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience.

Al-Okaili RN, Krejza J, Woo JH, Wolf RL, O'Rourke DM, Judy KD, Poptani H, Melhem ER.

Radiology. 2007 May;243(2):539-50.

PMID:
17456876
16.

Posterior fossa ependymoma.

Grady MS, Judy KD, Bigelow DC, Sinson GP, Rostomily R, Winn HR.

Skull Base. 2001 Aug;11(3):219-23. No abstract available.

17.

Stereotactic biopsy of brain stem masses: Decision analysis and literature review.

Samadani U, Stein S, Moonis G, Sonnad SS, Bonura P, Judy KD.

Surg Neurol. 2006 Nov;66(5):484-90; discussion 491.

PMID:
17084194
18.

Cerebrospinal fluid cytology to aid the diagnosis of cerebellopontine angle tumors.

Eisen MD, Smith PG, Judy KD, Bigelow DC.

Otol Neurotol. 2006 Jun;27(4):553-9.

PMID:
16791049
19.

Regional analysis of sinonasal ciliary beat frequency.

Shaari J, Palmer JN, Chiu AG, Judy KD, Cohen AS, Kennedy DW, Cohen NA.

Am J Rhinol. 2006 Mar-Apr;20(2):150-4.

PMID:
16686377
20.

Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla.

Wolf RL, Wang J, Wang S, Melhem ER, O'Rourke DM, Judy KD, Detre JA.

J Magn Reson Imaging. 2005 Oct;22(4):475-82.

PMID:
16161080
21.

Cerebral gumma mimicking glioblastoma multiforme.

Ances BM, Danish SF, Kolson DL, Judy KD, Liebeskind DS.

Neurocrit Care. 2005;2(3):300-2.

PMID:
16159080
22.

Intracranial capillary hemangioma: case report and review of the literature.

Simon SL, Moonis G, Judkins AR, Scobie J, Burnett MG, Riina HA, Judy KD.

Surg Neurol. 2005 Aug;64(2):154-9.

PMID:
16051010
23.

Hypoxia is important in the biology and aggression of human glial brain tumors.

Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS, Koch CJ.

Clin Cancer Res. 2004 Dec 15;10(24):8177-84.

24.

Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding.

Evans SM, Judy KD, Dunphy I, Jenkins WT, Nelson PT, Collins R, Wileyto EP, Jenkins K, Hahn SM, Stevens CW, Judkins AR, Phillips P, Geoerger B, Koch CJ.

Cancer Res. 2004 Mar 1;64(5):1886-92.

25.

Stereotactic brainstem biopsy is indicated for the diagnosis of a vast array of brainstem pathology.

Samadani U, Judy KD.

Stereotact Funct Neurosurg. 2003;81(1-4):5-9.

PMID:
14742957
26.

Late cognitive and radiographic changes related to radiotherapy: initial prospective findings.

Armstrong CL, Hunter JV, Ledakis GE, Cohen B, Tallent EM, Goldstein BH, Tochner Z, Lustig R, Judy KD, Pruitt A, Mollman JE, Stanczak EM, Jo MY, Than TL, Phillips P.

Neurology. 2002 Jul 9;59(1):40-8.

PMID:
12105305
27.

Risk factors affecting survival after brain metastases from non-small cell lung carcinoma: a follow-up study of 70 patients.

Abrahams JM, Torchia M, Putt M, Kaiser LR, Judy KD.

J Neurosurg. 2001 Oct;95(4):595-600.

PMID:
11596953
28.

Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme.

Telfeian AE, Philips MF, Crino PB, Judy KD.

J Exp Clin Cancer Res. 2001 Mar;20(1):5-10.

PMID:
11370829
29.

Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts.

Geoerger B, Tang CB, Cesano A, Visonneau S, Marwaha S, Judy KD, Sutton LN, Santoli D, Phillips PC.

Neuro Oncol. 2000 Apr;2(2):103-13. doi: 10.1093/neuonc/2.2.103.

30.

Use of a portable head mounted perimetry system to assess bedside visual fields.

Hollander DA, Volpe NJ, Moster ML, Liu GT, Balcer LJ, Judy KD, Galetta SL.

Br J Ophthalmol. 2000 Oct;84(10):1185-90.

31.

Acute mental status changes.

Sulkowski JA, Judy KD.

AACN Clin Issues. 1997 Aug;8(3):319-34; quiz 502-4. Review.

PMID:
9313371
32.

Gliomas: correlation of magnetic susceptibility artifact with histologic grade.

Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, Detre J.

Radiology. 1997 Feb;202(2):511-6.

PMID:
9015082
33.

Functional activation during an auditory comprehension task in patients with temporal lobe lesions.

Alsop DC, Detre JA, D'Esposito M, Howard RS, Maldjian JA, Grossman M, Listerud J, Flamm ES, Judy KD, Atlas SW.

Neuroimage. 1996 Aug;4(1):55-9.

PMID:
9345496
34.

Functional magnetic resonance imaging of regional brain activity in patients with intracerebral gliomas: findings and implications for clinical management.

Atlas SW, Howard RS 2nd, Maldjian J, Alsop D, Detre JA, Listerud J, D'Esposito M, Judy KD, Zager E, Stecker M.

Neurosurgery. 1996 Feb;38(2):329-38.

PMID:
8869061
35.

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

Judy KD, Olivi A, Buahin KG, Domb A, Epstein JI, Colvin OM, Brem H.

J Neurosurg. 1995 Mar;82(3):481-6.

PMID:
7861228
36.

Proposed toxic oxidant inhibitors fail to reduce brain edema.

Judy KD, Bulkley GB, Hedlund BE, Long DM.

Acta Neurochir Suppl (Wien). 1994;60:89-93.

PMID:
7976665

Supplemental Content

Support Center